30 closest matches · ranked by relevance
Diagnostic and/or Interventional Radiology Procedures
Primary: Rate of Major Vascular Complications — 0.7 Percentage of Procedures
Cardiac Arrhythmia
Primary: The Proportion of MRI Scans From Pacemakers or CRT-Ps Providing Sufficient Image Quality to Allow for a Diagnostic Interpretation. — 129 MRI Scans
Coronary Angiography
Primary: Evaluate the Total Volume of CM Used Comparing the DyeVert Group to the Control Group. — 38.0; 62.5 ml
Cardiovascular Disease
Primary: Image Quality — 0.96 Proportion of images rated equal/better
Coronary Artery Disease
Primary: Total Percutaneous Coronary Intervention (PCI) Iodinated Contrast Volume — 64.6; 90.8 ml
Sacroiliac Joint Pain · Sympathetically Maintained Pain
Primary: Pain Score — 2.2; 3.4 units on a scale
Interventional Vascular Conditions
Primary: Image Guidance Adequacy Collected Via Survey Questionnaire — 30 Participants
Cardiac Catheterization · Radiation Exposure
Primary: Radiation Dose to Primary Operator (RaySafe), Cardiac Catheterization — 18; 39 microsievert
Catheters, With or Without Malposition · Image Interpretation, Computer Assisted
Primary: Time for Completion of Tasks — 27.68; 22.90 seconds
Vascular Access Complication
Primary: Time to Successful First Stick in Minutes — 4.56; 6.24 minutes
Coronary Artery Disease
Primary: Technical Performance — 56.0 millimeters — p=0.0001
Metastatic or Recurrent Lesions in the Spine · Metastatic or Recurrent Lesions in the Pelvis
Primary: Maximum Radiation Dose — 7 cord/cauda max dose in Gy
Radiation Exposure to Operator
Primary: Operator Radiation Exposure — .65; .56 mSv
Stroke, Acute
Primary: Ischemic Stroke Diagnostic Accuracy (CBCT Versus CT) — 90; 90 percentage of gold standard
Peripheral Arterial Occlusive Disease
Primary: Level of Pain/Heat in the Lower Extremities Scored by the Participants on the Visual Analog Scale (VAS) Following Intra-arterial Administration of ISOVUE-250 or…
Renal Artery Obstruction
Primary: Percentage of Assessable Vascular Segments Using Gadobutrol-Enhanced MRA and Unenhanced MRA — 95.9; 77.6; 98.1; 81.7 Percentage of segments — p=<0.000
Prostate Cancer · Cancer of the PROSTATE · Prostatic Neoplasm
Primary: Keyword Description of Each Biopsy Sample — 89 percentage significant cancers detected
Peripheral Arterial Occlusive Disease
Primary: Level of Pain in the Lower Extremities Scored by the Participants on the Visual Analog Scale Following Intraarterial Administration of ISOVUE-250 or VISIPAQUE 270 in…
Contrast Enhanced Computed Tomography
Primary: Acceptable Image Quality — 100; 100; 100 percentage of participants
Overactive Bladder · Urinary Incontinence · Fecal Incontinence
Primary: Number of Participants With InterStim Implantation Following PNE With or Without Use of Fluoroscopy — 21; 18 Participants
Radiation Exposure · Enteral Nutrition
Primary: Time to Duodenal Intubation — 1.6; 4.1 Minutes
Peripheral Arterial Disease
Primary: Clinical Success — 20 Participants
Pulmonary Lesions · Pulmonary Nodules · Pulmonary Mass
Primary: Diagnostic Yield of Procedures; Number of Positive Diagnosis of Pulmonary Lesions — 51; 62; 58; 51 participants
Peripheral Arterial Disease (PAD)
Primary: Segment-level Sensitivity and Specificity of VE-MRI at 3 Ferumoxytol Dosing Levels and Differences in Sensitivity and Specificity by Dose Group — 71.8; 76.8; 81.8; 71.2…
Enlarged Prostate
Primary: Time for Prostatic Artery Catheterization — 273.40; 181.71; 206.38; 155.96 seconds
Carcinoma, Hepatocellular
Primary: Dose Area Product (DAP) — 184.2; 137.4 Gy.cm2 — p=<.001
Gastro-Intestinal Disorder
Primary: Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis — 283 participants
Vascular Access Complications
Primary: First Attempt Success Rate With Peripheral IV (PIV) Catheter Placement — 84; 90 Participants
Pain, Postoperative · Pain, Chronic
Primary: Intravenous Pain Medication — 63; 66 milligrams
Thrombosis
Primary: Total Number of Participants Who Completed the Study-Related Ultrasound (US) and Magnetic Resonance Imaging (MRI) With and Without Contrast — 133; 113; 113; 110…